NYSE: IBNICICI Bank Ltd Stock
$30.92+0.46 (+1.51%)
Updated Feb 4, 2026
IBN Price
$30.92
Fair Value Price
N/A
Market Cap
$110.11B
52 Week Low
$27.46
52 Week High
$34.57
P/E
18.36x
P/B
3.04x
P/S
3.21x
PEG
0.03x
Dividend Yield
N/A
Revenue
$34.26B
Earnings
$5.97B
Gross Margin
100%
Operating Margin
47.54%
Profit Margin
17.3%
Debt to Equity
7.47
Operating Cash Flow
$14B
Beta
0.65
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
IBN Overview
ICICI Bank Limited offers banking products and financial services for corporate and retail customers through a variety of delivery channels and specialized subsidiaries in the areas of investment banking, life, non-life insurance, venture capital, and asset management. ICICI Bank also offerfs online services through "ICICIStack.". The company was established on 1955 and is headquartered in Gujarat, India.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine IBN's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Bank
Industry Rating
D
IBN
Ranked#267 of 280
Ranked#267 of 280
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $6.63 | A | |
| $23.58 | B | |
| $37.90 | B |
Be the first to know about important IBN news, forecast changes, insider trades & much more!
IBN News
Overview
Due Diligence Score
–
Industry Average (38)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IBN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IBN ($30.92) is trading below its intrinsic value of $340.31, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IBN is good value based on its earnings relative to its share price (18.36x), compared to the US market average (41.75x)
P/E vs Market Valuation
IBN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more IBN due diligence checks available for Premium users.
Valuation
IBN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
18.36x
Industry
17.49x
Market
41.75x
IBN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IBN is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
IBN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.04x
Industry
1.41x
IBN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
IBN price to earnings growth (PEG)
For valuing profitable companies with growth potential
IBN is good value based... subscribe to Premium to read more.
PEG Value Valuation
IBN's financial health
Profit margin
Revenue
$34.5B
Net Income
$6.0B
Profit Margin
17.3%
IBN's Earnings (EBIT) of $16.29B... subscribe to Premium to read more.
Interest Coverage Financials
IBN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$309.2B
Liabilities
$272.7B
Debt to equity
7.47
IBN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IBN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$14.4B
Investing
-$9.0B
Financing
$654.0M
IBN's operating cash flow ($14.28B)... subscribe to Premium to read more.
Debt Coverage Financials
IBN vs Bank Stocks
ICICI Bank Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.